fashion -WSS

fashion

author：explore 2025-09-02 22:08:42 - browse：1

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Galapagos to make CAR

WSS

Oak Street deal isn't the answer to health care's woes

What Kate Middleton's cancer revelation might teach the world

Supreme Court to hear if Covid misinformation is protected speech

Cancer, immunology, HIV research ensnared in fetal tissue politics

STAT reporters are Pulitzer Prize finalists for investigative reporting

The United States must get value

focus

fashion

hotspot

Hollywood unions extend contract negotiations for actors

Mirador, a new biotech startup, launches with $400 million

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

WuXi Biologics execs register to lobby as Congress comes for the company

State Dept. review finds Biden bears some blame for Afghanistan failures

Galapagos to make CAR

Hepatitis C has a cure — but many Americans still lack access to it

Lilly’s weekly insulin works as well as daily products, new studies show

Anesthesiologist group: stop taking Ozempic before surgery

Novo Nordisk testing Wegovy against alcohol

leisure time

Pregnancy ages women, but effects reverse after delivery

Testing GLP

Fertility clinic egg and embryo storage is a disaster

U.K. officials, researchers try to ease path for bespoke genetic treatments

Readout Newsletter: Illumina, CRISPR, Regeneron

Hottest summer in 2,000 years puts focus on extreme heat, health

explore

hotspot

entertainment

hotspot